Results 1 to 10 of about 1,357,862 (296)

Case Report: Sneaky DCIS-like invasive ductal carcinoma of the breast in the setting of extensive DCIS [PDF]

open access: yesFrontiers in Medicine
In most cases, invasive ductal carcinoma (IDC) of the breast is identifiable when it presents with classic infiltrative growth patterns. However, a subset of IDC can present in a very sneaky way, significantly mimicking the appearance of ductal carcinoma
Chong Chen   +9 more
doaj   +2 more sources

A case report of coexistence of invasive ductal carcinoma and malignant phyllodes tumor in a single breast mass [PDF]

open access: yesMajallah-i Zanān, Māmā̓ī va Nāzā̓ī-i Īrān, 2022
Introduction: Coexistence of malignant phyllodes tumor and invasive ductal carcinoma in a breast lesion is a very rare medical condition. In this study, a case of coexistence of invasive ductal carcinoma and malignant phyllodes tumor in a single breast ...
Mahsa Akbari Oryani, Zahra Nikfarjam
doaj   +1 more source

Association of clinico-pathological and immunohistochemical prognostic parameters with presence of ductal carcinoma in-situ in an invasive ductal carcinoma of breast

open access: yesJournal of Pathology of Nepal, 2023
Background: The clinical outcome of breast carcinoma varies in each individual due to its molecular heterogeneity. There is a rising interest in whether the associated ductal carcinoma in-situ in invasive ductal carcinoma of breast affects the prognosis ...
Dhivya Balaiya   +2 more
doaj   +1 more source

Synchronous invasive ductal carcinoma in encapsulated papillary ductal carcinoma [PDF]

open access: yesJournal of Surgical Case Reports, 2016
Encapsulated papillary ductal carcinoma (EPC) of the breast is a rare form of cancer with defining histopathology of encapsulation. These lesions are typically indolent but may rarely have concomitant, synchronous invasive lesions.This report details a 56-year-old black female who presented with a palpable left breast mass.
Regan, J.P.   +2 more
openaire   +2 more sources

Potential biomarkers of ductal carcinoma in situ progression

open access: yesBMC Cancer, 2020
Background Ductal carcinoma in situ is a non-obligate precursor of invasive breast carcinoma and presents a potential risk of over or undertreatment. Finding molecular biomarkers of disease progression could allow for more adequate patient treatment.
Raquel Spinassé Dettogni   +17 more
doaj   +1 more source

Invasive Lobular Carcinoma of Breast with Extracellular Mucin: A Novel Entity

open access: yesJournal of Medical Sciences and Health, 2023
Invasive carcinoma of no special type (NST) or ductal carcinoma is the most common type of invasive breast cancers. Invasive lobular carcinoma (ILC) is the most common special variant amongst breast cancers that lacks some of the common features
Md. Samim Iqbal   +5 more
doaj   +1 more source

Invasive ductal carcinoma ex pleomorphic adenoma of the lacrimal gland - a long term follow-up case

open access: yesHuman Pathology: Case Reports, 2017
We experienced a case of malignant orbital tumor in a 72-year-old Japanese man. He noticed protrusion of his left eye, and received resection of the left orbital tumor.
Naoko Nambu   +7 more
doaj   +1 more source

Invasive Lobular Carcinoma of the Breast with Extracellular Mucin- A New Rare Variant [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2015
Historically, extracellular mucin secretion is by default a feature of ductal carcinoma. Lobular carcinoma is known to be associated with only intracytoplasmic mucin production and signet ring cells.
Vaibhav Bhika Bari   +2 more
doaj   +1 more source

Unusual Metastasis of Lobular Carcinoma of the Breast

open access: yesHaseki Tıp Bülteni, 2018
Invasive lobular carcinoma is the second most common type of invasive breast cancer accounting for approximately 5-10% of all invasive breast carcinomas. The metastatic patterns of lobular and ductal carcinomas are significantly different.
Songül Peltek Özer, Saime Gül Barut
doaj   +1 more source

The incidence of discordant clinical and genomic risk in patients with invasive lobular or ductal carcinoma of the breast: a National Cancer Database Study

open access: yesnpj Breast Cancer, 2021
When molecular testing classifies breast tumors as low risk but clinical risk is high, the optimal management strategy is unknown. One group of patients who may be more likely to have such discordant risk are those with invasive lobular carcinoma of the ...
Mary Kathryn Abel   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy